COVID-19: HHS Decree Looks To Shield Manufacturers From Future Liability Suits
Declaration provides legal immunity under emergency preparedness act
The US Department of Health and Human Services is offering some legal protection to developers of devices and diagnostics for use in the fight against the novel coronavirus.
You may also be interested in...
The report outlines the lawsuits that the Food and Drug Law Institute believes could have the greatest impacts on industries regulated by the US FDA.
Manufacturers face risk of whistle-blower suits and government enforcement actions when emergency use authorizations expire and pandemic recedes, attorneys say, but interaction with FDA and documentation may mitigate risk.
Three attorneys got out their crystal balls to forecast what device industry sectors may come in for enforcement scrutiny related to the COVID-19 pandemic.